FACTORS DETERMINING THE CLINICAL SIGNIFICANCE OF DEPIPTIDYL PEPTIDASE 4 INHIBITORS IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS. Wor.Bul.Pub.Helt. [Internet]. 2022 Mar. 13 [cited 2026 Apr. 18];8:67-72. Available from: https://www.scholarexpress.net/index.php/wbph/article/view/651